Role of Plasminogen Activator Inhibitor-1 in Senescence and Aging

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Seminars in Thrombosis and Hemostasis

• Publication date

  2014-08-31

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1055/s-0034-1387883PMID 25173500PMCID PMC6563930
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Age-Related Changes in Aortic Valve Hemostatic Protein Regulation

  2014cited by this paper
• PAI-1–regulated extracellular proteolysis governs senescence and survival in Klotho mice

  2014cited by this paper
• Expression of uPA, tPA, and PAI-1 in Calcified Aortic Valves

  2014cited by this paper
• Trends in the prevalence, awareness, treatment and control of high low density lipoprotein-cholesterol among United States adults from 1999-2000 through 2009-2010.

  2013cited by this paper
• Plasminogen Activator Inhibitor-1 Antagonist TM5441 Attenuates N&ohgr;-Nitro-L-Arginine Methyl Ester–Induced Hypertension and Vascular Senescence

  2013cited by this paper
• Plasminogen activator inhibitor-1 (PAI-1) expression in relation to hypoxia and oncoproteins in clinical cervical tumors

  2012cited by this paper
• Plasminogen activator inhibitor 1 - insulin-like growth factor binding protein 3 cascade regulates stress-induced senescence

  2012cited by this paper
• A senescent cell bystander effect: senescence-induced senescence

  2012cited by this paper
• SIRT6 protects human endothelial cells from DNA damage, telomere dysfunction, and senescence

  2012cited by this paper
• A Novel mRNA Binding Protein Complex Promotes Localized Plasminogen Activator Inhibitor-1 Accumulation at the Myoendothelial Junction

  2012cited by this paper
• Four faces of cellular senescence

  2011cited by this paper
• Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders

  2011cited by this paper
• Venous thrombosis risk associated with plasma hypofibrinolysis is explained by elevated plasma levels of TAFI and PAI-1.

  2010cited by this paper
• Plasminogen Activator Inhibitor-1 Regulates Myoendothelial Junction Formation

  2010cited by this paper
• The Pro/Pro genotype of the p53 codon 72 polymorphism modulates PAI-1 plasma levels in ageing.

  2009cited by this paper
• Relationships of PAI-1 levels to central obesity and liver steatosis in a sample of adult male population in southern Italy

  2009cited by this paper
• A comparison among HER2, TP53, PAI-1, angiogenesis, and proliferation activity as prognostic variables in tumours from 408 patients diagnosed with early breast cancer

  2008cited by this paper
• Opposing roles for p16Ink4a and p19Arf in senescence and ageing caused by BubR1 insufficiency

  2008cited by this paper
• Suppression of the p53-Dependent Replicative Senescence Response by Lysophosphatidic Acid Signaling

  2008cited by this paper
• Cellular senescence: when bad things happen to good cells

  2007cited by this paper
• Human visceral adipose tissue and the plasminogen activator inhibitor type 1

  2007cited by this paper
• DNA damage, cellular senescence and organismal ageing: causal or correlative?

  2007cited by this paper
• Reactive site‐dependent phenotypic alterations in plasminogen activator inhibitor‐1 transgenic mice

  2007cited by this paper
• Senescence, Wound Healing, and Cancer: the PAI-1 Connection

  2006cited by this paper
• Plasminogen activator inhibitor-1 is a critical downstream target of p53 in the induction of replicative senescence

  2006cited by this paper
• The power and the promise of oncogene-induced senescence markers

  2006cited by this paper
• Adipocytokines and incident diabetes mellitus in older adults: the independent effect of plasminogen activator inhibitor 1.

  2006cited by this paper
• Pivotal role of PAI-1 in a murine model of hepatic vein thrombosis.

  2006cited by this paper
• Increased plasminogen activator inhibitor type-1 (PAI-1) in the heart as a function of age.

  2006cited by this paper
• PAI-1 and the Metabolic Syndrome: Links, Causes, and Consequences

  2006cited by this paper
• Senescent cells, tumor suppression, and organismal aging: good citizens, bad neighbors.

  2005cited by this paper
• Regulation of Lipopolysaccharide-Induced Lung Inflammation by Plasminogen Activator Inhibitor-1 through a JNK-Mediated Pathway

  2005cited by this paper
• Tumor necrosis factor alpha activates the human plasminogen activator inhibitor-1 gene through a distal nuclear factor kappaB site.

  2004cited by this paper
• Tumor Necrosis Factor α Activates the Human Plasminogen Activator Inhibitor-1 Gene through a Distal Nuclear Factor κB Site*

  2004cited by this paper
• Aging of stromal-derived human breast fibroblasts might contribute to breast cancer progression

  2003cited by this paper
• Endothelial Cell Senescence in Human Atherosclerosis: Role of Telomere in Endothelial Dysfunction

  2002cited by this paper
• Age-Dependent Spontaneous Coronary Arterial Thrombosis in Transgenic Mice That Express a Stable Form of Human Plasminogen Activator Inhibitor-1

  2002cited by this paper
• Potential roles of plasminogen activator system in coronary vascular remodeling induced by long-term nitric oxide synthase inhibition.

  2002cited by this paper
• Elevated levels of acute-phase proteins and plasminogen activator inhibitor-1 predict the development of type 2 diabetes: the insulin resistance atherosclerosis study.

  2002cited by this paper
• Aging accelerates endotoxin-induced thrombosis : increased responses of plasminogen activator inhibitor-1 and lipopolysaccharide signaling with aging.

  2002cited by this paper
• Plasminogen activator inhibitor-1 is a major stress-regulated gene: Implications for stress-induced thrombosis in aged individuals

  2002cited by this paper
• Increased Expression of Plasminogen Activator Inhibitor-1 with Fibrin Deposition in a Murine Model of Aging, "Klotho" Mouse

  2002cited by this paper
• Plasma PAI-1 Levels in Obese Children – Effect of Weight Loss and Influence of PAI-1 Promoter 4G/5G Genotype

  2001cited by this paper
• Plasmin and Matrix Metalloproteinases in Vascular Remodeling

  2001cited by this paper
• Plasminogen Activator Inhibitor Type 1 Is Increased in the Arterial Wall of Type II Diabetic Subjects

  2001cited by this paper
• Plasminogen Activator Inhibitor-1 Deficiency Prevents Hypertension and Vascular Fibrosis in Response to Long-term Nitric Oxide Synthase Inhibition

  2001cited by this paper
• Function of the plasminogen/plasmin and matrix metalloproteinase systems after vascular injury in mice with targeted inactivation of fibrinolytic system genes.

  1998cited by this paper
• Increased plasminogen activator inhibitor type 1 in coronary artery atherectomy specimens from type 2 diabetic compared with nondiabetic patients: a potential factor predisposing to thrombosis and its persistence.

  1998cited by this paper
• High plasminogen activator inhibitor and tissue plasminogen activator levels in plasma precede a first acute myocardial infarction in both men and women: evidence for the fibrinolytic system as an independent primary risk factor.

  1998cited by this paper
• PAI-1, Obesity, Insulin Resistance and Risk of Cardiovascular Events

  1997cited by this paper
• Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a.

  1997cited by this paper
• Mutation of the mouse klotho gene leads to a syndrome resembling ageing

  1997cited by this paper
• Inhibitors of fibrinolysis are elevated in atherosclerotic plaque.

  1996cited by this paper
• Altered expression of plasminogen activator and plasminogen activator inhibitor during cellular senescence.

  1996cited by this paper
• The insulin resistance atherosclerosis study (IRAS) objectives, design, and recruitment results.

  1995cited by this paper
• Plasminogen activator expression in human atherosclerotic lesions.

  1995cited by this paper
• Plasminogen activator system in human coronary atherosclerosis.

  1995cited by this paper
• Trends in the prevalence, awareness, treatment, and control of hypertension in the adult US population. Data from the health examination surveys, 1960 to 1991.

  1995cited by this paper
• Differential growth state‐dependent regulation of plasminogen activator inhibitor type‐1 expression in senescent IMR‐90 human diploid fibroblasts

  1995cited by this paper
• The Effect of Ageing on Platelet Function and Fibrinolytic Activity

  1995cited by this paper
• Senescence-dependent regulation of type 1 plasminogen activator inhibitor in human vascular endothelial cells.

  1995cited by this paper
• Overexpression of plasminogen activator inhibitor type‐1 in senescent fibroblasts from normal subjects and those with Werner syndrome

  1994cited by this paper
• Role of plasminogen activator inhibitor type 1 in the pathogenesis of coronary artery diseases.

  1994cited by this paper
• Age-related changes in the hemostatic system

  1993cited by this paper
• Increased type 1 plasminogen activator inhibitor gene expression in atherosclerotic human arteries.

  1992cited by this paper
• Pharmacological modulation of the endotoxin‐induced increase in plasminogen activator inhibitor activity in rats

  1992cited by this paper
• Endotoxin induction of plasminogen activator and plasminogen activator inhibitor type 1 mRNA in rat tissues in vivo.

  1990cited by this paper
• Regulation of type 1 plasminogen activator inhibitor gene expression in cultured bovine aortic endothelial cells. Induction by transforming growth factor-beta, lipopolysaccharide, and tumor necrosis factor-alpha.

  1989cited by this paper
• Plasminogen activator inhibitor in plasma: risk factor for recurrent myocardial infarction.

  1987cited by this paper
• Increase in Plasma Concentrationof Plasminogen Activator Inhibitor, Fibrinogen, von Willebrand Factor, Factor VIII: Cand in Erythrocyte Sedimentation Rate with Age

  1986cited by this paper
• Characteristics affecting fibrinolytic activity and plasma fibrinogen concentrations.

  1979cited by this paper

• Integration of Multi-Omics and Machine Learning Identifies TGFB1 and SERPINE1 as Biomarkers of Vascular Smooth Muscle Cell Senescence in Intracranial Aneurysms

  2026cites this paper
• Plasminogen activator inhibitor 1 promotes aortic aging–like pathophysiology in humans and mice

  2025cites this paper
• The Role of p53‐Mediated Cellular Senescence in Idiopathic Pulmonary Fibrosis

  2025cites this paper
• PAI-1 is a common driver of aging and diverse diseases

  2025cites this paper
• The significance of PAI-1 expression in chronic diseases: from metabolic syndrome, emotional stress and chronic kidney disease to aging

  2025cites this paper
• Role of plasminogen activator inhibitor-1 (PAI-1) in age-related cardiovascular pathophysiology.

  2025cites this paper
• Neuroinflammaging and the Immune Landscape: The Role of Autophagy and Senescence in Aging Brain

  2025cites this paper
• A novel multiplex RNAi therapy simultaneously targets Hif1a and Hif2a to defy retinal degeneration in two models of AMD

  2025cites this paper
• Preeclampsia as a Study Model for Aging: The Klotho Gene Paradigm

  2025cites this paper
• The effect of epigenetic aging on neurodegenerative diseases: a Mendelian randomization study

  2024cites this paper
• Older patients affected by COVID-19: investigating the existence of biological phenotypes

  2024cites this paper
• Causal effects of cardiovascular health on five epigenetic clocks

  2024cites this paper
• Current insights and future directions of LncRNA Morrbid in disease pathogenesis

  2024cites this paper
• Unconventional localization of PAI-1 in PML bodies: A possible link with cellular growth of endothelial cells

  2024cites this paper
• PAI-1 as a critical factor in the resolution of sepsis and acute kidney injury in old age

  2024cites this paper
• “Super” SERPINs—A stabilizing force against fibrinolysis in thromboinflammatory conditions

  2023cites this paper
• Involvement of plasminogen activator inhibitor-1 in p300/p53-mediated age-related atrial fibrosis

  2023cites this paper
• Impact of lipopolysaccharide-induced acute lung injury in aged mice

  2023cites this paper
• Association of prothrombin complexe concentrate with venous thrombosis after cardiac surgery: a case-control study

  2023cites this paper
• Pharmacological inhibition of plasminogen activator inhibitor-1 prevents memory deficits and reduces neuropathology in APP/PS1 mice

  2023cites this paper
• Development of a DNA damage-induced senescence model in osteoarthritic chondrocytes

  2023cites this paper
• Effects of copy number variations on longevity in late-onset Alzheimer’s disease patients: insights from a causality network analysis

  2023cites this paper
• Identification of Genomic Loci Regulating Platelet Plasminogen Activator Inhibitor-1 in Mice.

  2023cites this paper
• Defining regorafenib as a senomorphic drug: therapeutic potential in the age-related lung disease emphysema

  2023cites this paper
• PGF2α-FP Receptor Ameliorates Senescence of VSMCs in Vascular Remodeling by Src/PAI-1 Signal Pathway

  2022cites this paper
• Haemostasis and fibrinolysis after regular high-intensity interval training in patients with coronary artery disease: a randomised controlled trial

  2022cites this paper
• Distinct expression and function of breast cancer metastasis suppressor 1 in mutant P53 glioblastoma

  2022cites this paper
• The Biological Role of Pleural Fluid PAI-1 and Sonographic Septations in Pleural Infection: Analysis of a Prospectively Collected Clinical Outcome Study.

  2022cites this paper
• Comparison of plasminogen activator inhibitor-1 levels in chronic hepatitis B patients with hepatic cirrhosis and without hepatic cirrhosis

  2022cites this paper
• Pathophysiological Aspects of Aging in Venous Thromboembolism: An Update

  2022cites this paper
• Irisin improves delayed bone repair in diabetic female mice

  2022cites this paper
• Transcriptomic profiling and differential analysis revealed the neurodevelopmental toxicity and mechanisms of zebrafish (Danio rerio) larvae in response to tetrabromobisphenol A bis(2-hydroxyethyl) ether (TBBPA-DHEE) exposure.

  2022cites this paper
• The Role of Fibrinolytic System in Health and Disease

  2022cites this paper
• Antibodies to blood coagulation components are implicated in patients with multiple sclerosis.

  2022cites this paper
• Expanded CUG Repeat RNA Induces Premature Senescence in Myotonic Dystrophy Model Cells

  2022cites this paper
• Phosphate and Cellular Senescence.

  2022cites this paper
• Unveiling E2F4, TEAD1 and AP-1 as regulatory transcription factors of the replicative senescence program by multi-omics analysis

  2022cites this paper
• Neuroprotective Effect of Plasminogen Activator Inhibitor-1 Antagonist in the Rat Model of Mild Traumatic Brain Injury

  2021cites this paper
• Plasminogen activator inhibitor type-1 is a negative regulator of hematopoietic regeneration in the adipocyte-rich bone marrow microenvironment.

  2021cites this paper
• PAI‐1 induction during kidney injury promotes fibrotic epithelial dysfunction via deregulation of klotho, p53, and TGF‐β1‐receptor signaling

  2021cites this paper
• Exercise Intolerance in Older Adults With Heart Failure With Preserved Ejection Fraction: JACC State-of-the-Art Review.

  2021cites this paper
• Interconnections between Inflammageing and Immunosenescence during Ageing

  2021cites this paper
• Use of Diterpene Ginkgolides Meglumine Injection to Regulate Plasma Levels of PAI-1 and t-PA in Patients With Acute Atherosclerotic Cerebral Infarction

  2021cites this paper
• The Role of Clock Genes in Fibrinolysis Regulation: Circadian Disturbance and Its Effect on Fibrinolytic Activity

  2020cites this paper
• PAI-1, the Plasminogen System, and Skeletal Muscle

  2020cites this paper
• Can Blood-Circulating Factors Unveil and Delay Your Biological Aging?

  2020cites this paper
• Impaired ECM Remodeling and Macrophage Activity Define Necrosis and Regeneration Following Damage in Aged Skeletal Muscle

  2020cites this paper
• Functional alterations and transcriptomic changes during zebrafish cardiac aging

  2020cites this paper
• Drug Targeting of Plasminogen Activator Inhibitor-1 Inhibits Metabolic Dysfunction and Atherosclerosis in a Murine Model of Metabolic Syndrome

  2020cites this paper
• Modulation of soluble receptor for advanced glycation end-products (RAGE) isoforms and their ligands in healthy aging

  2019cites this paper
• Age- and Nicotine-Associated Gene Expression Changes in the Hippocampus of APP/PS1 Mice

  2019cites this paper
• Impact of C-reactive protein on osteo-/chondrogenic transdifferentiation and calcification of vascular smooth muscle cells

  2019cites this paper
• Mechanisms of Fibrosis in Regeneration of Aged Skeletal Muscle

  2019influential citation
• Patient-derived cell line models revealed therapeutic targets and molecular mechanisms underlying disease progression of high grade serous ovarian cancer.

  2019cites this paper
• Inhibition of nucleotide synthesis promotes replicative senescence of human mammary epithelial cells

  2019cites this paper
• Dkk (Dickkopf) Proteins.

  2019cites this paper
• C2-Ceramide-Induced Rb-Dominant Senescence-Like Phenotype Leads to Human Breast Cancer MCF-7 Escape from p53-Dependent Cell Death

  2019cites this paper
• Hemostasis and Thrombosis in the Oldest Old

  2018cites this paper
• Stress/inflammation and pai-1 as stellar processes in the aging and associated pathologies

  2018cites this paper
• Activation of the bile acid receptor GPBAR1 (TGR5) ameliorates interleukin-1β (IL-1β)- induced chondrocytes senescence.

  2018cites this paper
• Kallistatin attenuates endothelial senescence by modulating Let‐7g‐mediated miR‐34a‐SIRT1‐eNOS pathway

  2018cites this paper
• Advances in Senotherapies

  2018cites this paper
• Inhibition of nucleotide synthesis mediates replicative senescence of human mammary epithelial cells

  2018cites this paper
• Safety and efficacy of stereotactic aspiration with fibrinolysis for deep-seated spontaneous intracerebral hemorrhages: A single-center experience.

  2017cites this paper
• Aging and Thrombosis: The Role of Genetic Factors

  2017cites this paper
• The Plasminogen Activation System

  2017cites this paper
• Plasminogen Activator Inhibitor-1 is Regulated Through Dietary Fat Intake and Heritability: Studies in Twins

  2017cites this paper
• Identification and characterization of a metastatic suppressor BRMS1L as a target gene of p53

  2017cites this paper
• Latency transition of plasminogen activator inhibitor type 1 is evolutionarily conserved

  2017cites this paper
• Getting Old through the Blood: Circulating Molecules in Aging and Senescence of Cardiovascular Regenerative Cells

  2017cites this paper
• Serpine 1 induces alveolar type II cell senescence through activating p53‐p21‐Rb pathway in fibrotic lung disease

  2017cites this paper
• The footprint of the ageing stroma in older patients with breast cancer

  2017cites this paper
• Even- and odd-chain saturated fatty acids in serum phospholipids are differentially associated with adipokines

  2017cites this paper
• Acute Fibrinolysis Shutdown after Injury Occurs Frequently and Increases Mortality: A Multicenter Evaluation of 2,540 Severely Injured Patients.

  2016cites this paper
• A small molecule inhibitor of PAI-1 protects against doxorubicin-induced cellular senescence

  2016cites this paper
• Generation of human iPSCs from urine derived cells of patient with a novel heterozygous PAI-1 mutation

  2016cites this paper
• Truncated Plasminogen Activator Inhibitor-1 Protein Protects From Pulmonary Fibrosis Mediated by Irradiation in a Murine Model.

  2016cites this paper
• Generation of human iPSCs from urine derived cells of a patient with a novel homozygous PAI-1 mutation.

  2016cites this paper
• Metabolic and Phenotypic Differences between Mice Producing a Werner Syndrome Helicase Mutant Protein and Wrn Null Mice

  2015cites this paper
• Impact of vitamin C on the cardiometabolic and inflammatory profiles of mice lacking a functional Werner syndrome protein helicase.

  2015cites this paper
• Aging and thrombotic tendency

  2015cites this paper
• Clinical strategies and animal models for developing senolytic agents.

  2015influential citation
• Age-Related Changes in Thrombosis and Hemostasis

  2014cites this paper